LifeSciVoiceFashion Trends and Culture

R&D
- Research & Development
  
  Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data
  
  Editorial Team - September 18, 2024 0
  
  Two medications have been shown to drastically alter the prognosis for the fatal skin disease melanoma, according to information gained through a decade of...
  
  Research & Development
  
  Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
  
  Editorial Team - September 5, 2024 0
  
  Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...
  
  Research & Development
  
  Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
  
  Editorial Team - August 27, 2024 0
  
  Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...
  
  Research & Development
  
  Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
  
  Editorial Team - July 18, 2024 0
  
  Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....
Clinical
- Clinical
  
  AbbVie’s Parkinson’s Drug Meets Phase 3 Trial Goal
  
  Editorial Team - October 1, 2024 0
  
  AbbVie has disclosed that its late-stage monotherapy prospect substantially decreased the impact of the condition in patients as contrasted with placebo on the same...
  
  Clinical
  
  Experimental Pill by Novo Nordisk Shown to Have Side Effects in Trial
  
  Editorial Team - September 26, 2024 0
  
  Amycretin, Novo Nordisk's much-anticipated experimental weight-loss drug, was found to be safe in an early-stage trial, with mild to moderate side effects, the company...
  
  Clinical
  
  Biogen and UCB’s lupus drug achieves primary objective in late-stage trial
  
  Editorial Team - September 26, 2024 0
  
  Biogen and UCB have published a listing of a late-stage clinical trial of dapirolizumab pegol, an experimental drug for treating lupus, a disease in...
  
  Clinical
  
  ITeos drug in combination with GSK’s Jemperli shows positive response in lung cancer treatment
  
  Editorial Team - September 18, 2024 0
  
  Results from a mid-stage clinical trial conducted by a small biotechnology company iTeos Therapeutics have revealed that when taken in combination with GSK immunotherapy...
Manufacturing
- Manufacturing
  
  Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
  
  Editorial Team - June 26, 2024 0
  
  It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...
  
  Manufacturing
  
  French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
  
  Editorial Team - June 8, 2024 0
  
  In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...
  
  Manufacturing
  
  Gerresheimer Increases the Capabilities of Medical Systems in the USA
  
  Editorial Team - May 28, 2024 0
  
  Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...
  
  Manufacturing
  
  Novo Nordisk invests $560 million to increase Chinese medicine production
  
  Editorial Team - March 22, 2024 0
  
  Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
Commercial
- All Brand & Marketing
  
  Commercial
  
  Repair Biotechnologies to Leverage Genevant Sciences’ LNP Technology for Atherosclerosis Treatment
  
  Editorial Team - October 1, 2024 0
  
  Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to gain access to Genevant’s lipid nanoparticle (LNP) technology delivery system. Repair will specifically...
  
  Commercial
  
  AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai
  
  Editorial Team - October 1, 2024 0
  
  Immunai, a biotechnology company based in New York, has partnered with AstraZeneca in a multiyear endeavor to try and change the cancer immunotherapy trials...
  
  Commercial
  
  Vicebio Raises $100 Million in Series B Funding to Advance RSV Combination Vaccine Through Phase I
  
  Editorial Team - September 26, 2024 0
  
  Vicebio, the British biotech, has closed a $100 million Series B funding round as it advances a Phase I study of its bivalent vaccine...
Technology
- Technology
  
  PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
  
  Editorial Team - September 26, 2024 0
  
  Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...
  
  Technology
  
  Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
  
  Editorial Team - August 8, 2024 0
  
  Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...
  
  Technology
  
  AI Firm Formation Bags $372 Series D Funding
  
  Editorial Team - June 30, 2024 0
  
  In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...
  
  Technology
  
  Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
  
  Mohsin Riaz - June 21, 2024 0
  
  California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...
Regulatory
- Regulatory
  
  FDA authorizes the first novel schizophrenia therapy in decades
  
  Editorial Team - October 1, 2024 0
  
  The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizophrenia drug Cobenfy, the first new chemical entity to treat the severe, chronic...
  
  Regulatory
  
  Illumina Gets Favorable Decision Regarding Grail Acquisition
  
  Editorial Team - September 6, 2024 0
  
  In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...
  
  Regulatory
  
  Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
  
  Editorial Team - September 1, 2024 0
  
  Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...
  
  Regulatory
  
  Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
  
  Editorial Team - August 29, 2024 0
  
  Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...
Insights
- Insights
  
  The Future of Gene Therapies: Three Trends
  
  Philip Cyr, Richard Macaulay , Andy Kinley - March 18, 2023 0
  
  “Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...
  
  Insights
  
  A Patient Centric Approach to Clinical Research is Key for Product Development
  
  Hera Arham - February 22, 2023 0
  
  Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...
  
  Insights
  
  The FDA and AAV-Based Gene Therapy Safety: What You Should Know
  
  Deborah Phippard - PHD , Philip Cyr - January 29, 2023 0
  
  Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...
  
  Insights
  
  Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
  
  Jassi Chadha - January 16, 2023 0
  
  The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
More
Podcast

Life Sciences Voice Top Industry Leaders Award

Life Sciences Voice Top Industry Leaders Award recognizes the most dynamic leaders in the Life Sciences industry. These individuals are making a significant impact by delivering transformation that is moving the industry forward. They are the industry's most creative and innovative minds working on important initiatives and delivering extraordinary results.

Congratulations to all the 2023 winners! The Life Sciences Voice community is thrilled to come together and celebrate their success!

Winners List 2023

Lynelle Hoch

President, Cell Therapy Organization

Bristol Myers Squibb

Thomas McCourt

Chief Executive Officer

Ironwood

Aida Habtezion

MD, SVP, Chief Medical Officer, and Head of Worldwide

Pfizer

Matthew J. Hawryluk, Ph.D

EVP, Chief Business Officer and Cambridge Site Head

Gritstone

Marina Hong

SVP, Head of Human Resources U.S.

Bayer

Read More

Mark Hill
Chief Digital Information Officer
CSL

Read More

Lei Ding
SVP of Market Access and Commercial Capabilities
Astellas

Read More

Negelle Morris
SVP, Cardiometabolic Sales
Novo Nordisk

Read More

Trevor Martin
CEO
Co-founder, Chief Executive Officer Mammoth Biosciences

Read More

Mark Litton
President & Chief Executive Officer
Athira Pharma

Read More

Chitra Narasimhachari
Vice President of Global Decision Sciences and Insights
Gilead Sciences

Read More

John A. Scarlett
Chairman of the Board, President and CEO
Geron Corporation

Read More

Patrik Jonsson
Executive Vice President
Eli Lilly and Company

Read More

Bob Jahr
Chief Commercial Officer
Sobi, NA

Read More

Mahesh Karande
President and Chief Executive Officer
Omega Therapeutics

Read More

Kengo Takishima
President and Chief Executive Officer
Baylor Genetics

Read More

Jag Dosanjh
SVP, AbbVie and President, Neuroscience and Eye Care
Abbvie

Read More

Kate Haviland
Chief Executive Officer
Blueprint Medicines

Read More

James Fullarton
VP Global Commercial IT
Smith+Nephew

Read More

Bob Ragusa
President and Chief Executive Officer
GRAIL LLC

Read More

William K. Moss
Chief Executive Officer
3Aware, Inc.

Read More

Ashish Kathuria
Business Unit Head
Axtria

Read More

James Swanson
EVP, Chief Information Officer
Johnson & Johnson

Read More

GENE G. KINNEY
President and Chief Executive Officer
Prothena Corporation

Read More

Shobie Ramakrishnan
Chief Digital and Technology Officer
GSK

Read More

Caroline J Loew
Chief Executive Officer
Mural Oncology

Read More

Amit K. Sachdev
Chief Patient and External Affairs Officer
Vertex

Read More

Bobak Azamian
CEO
Tarsus Pharmaceuticals

Read More

Michael Quirk
Chief Scientific Officer
Sage Therapeutics

Read More

Pam Cheng
EVP, Global Operations, IT & Chief Sustainability Officer
AstraZeneca

Read More

Editor Picks

Ventyx’s Crohn’s Disease Medicine Fails to Make a Mark in Phase 2 Trial

Commercial Editorial Team - July 30, 2024 0

In a phase 2 experiment, the Crohn's disease medication developed by Ventyx Biosciences did...

Read more

Aridis receives FDA agreement on single Phase 3 study for AR-301

Regulatory Editorial Team - May 31, 2023 0

Aridis Pharmaceuticals, Inc. received encouraging FDA feedback on their planned Phase 3...

Read more

J&J Bags FDA Approval For Pulmonary Arterial Combo Tablet

Regulatory Editorial Team - March 28, 2024 0

As anticipated this week, the FDA is poised to authorize Merck's pioneering treatment for...

Read more

Must Read

Repair Biotechnologies to Leverage Genevant Sciences’ LNP Technology for Atherosclerosis Treatment

Commercial Editorial Team - October 1, 2024 0

Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to gain access to...

Read more

AbbVie’s Parkinson’s Drug Meets Phase 3 Trial Goal

Clinical Editorial Team - October 1, 2024 0

AbbVie has disclosed that its late-stage monotherapy prospect substantially decreased the impact of the...

Read more

AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai

Commercial Editorial Team - October 1, 2024 0

Immunai, a biotechnology company based in New York, has partnered with AstraZeneca in a...

Read more

Hot Topics
Clinical251
Commercial250
Regulatory216
Research & Development87
Manufacturing45
Newsletter45
Technology37
News31

LifeSciVoice

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
LinkedIn
Twitter

© Copyright - Life Sciences Voice

R&D

Clinical

Manufacturing

Commercial

Technology

Regulatory

Insights

More

Awards

Editorial

Contact

Podcast

LifeNewsLife Science

LifeNewsFashion Trends and Culture

LifeSciVoiceFashion Trends and Culture

LifeNewsFashion Trends and Culture

Life Sciences Voice Top Industry Leaders Award

Winners List 2023

Lynelle Hoch

Thomas McCourt

Aida Habtezion

Matthew J. Hawryluk, Ph.D

Marina Hong

Mark Hill

Lei Ding

Negelle Morris

Trevor Martin

Mark Litton

Chitra Narasimhachari

John A. Scarlett

Patrik Jonsson

Bob Jahr

Mahesh Karande

Kengo Takishima

Jag Dosanjh

Kate Haviland

James Fullarton

Bob Ragusa

William K. Moss

Ashish Kathuria

James Swanson

GENE G. KINNEY

Shobie Ramakrishnan

Caroline J Loew

Amit K. Sachdev

Bobak Azamian

Michael Quirk

Pam Cheng

Editor Picks

Must Read

Hot Topics

LifeSciVoice

About Us

Follow Us